News

Pharmabiz1d
US FDA grants orphan drug designation to ImCheck’s ICT01 for treatment of acute myeloid leukaemia
Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...
Targeted Oncology3d
Optimizing AML Treatment: ICT01 Receives FDA Orphan Drug Designation
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
The Manila Times4d
ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia
ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...
The Manila Times4d
Buxton, Elevar, and Audiense Unite Under a New Brand: Audiense
Fort Worth, TX, July 18, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE ...